Advanced cell culture techniques and personalised medicine for cystic fibrosis

Jeffrey M. Beekman (Utrecht, Netherlands)

Source: International Congress 2015 – Respiratory research in the Netherlands
Session: Respiratory research in the Netherlands
Session type: Symposium
Number: 1733
Disease area: Paediatric lung diseases

WebcastSlide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Jeffrey M. Beekman (Utrecht, Netherlands). Advanced cell culture techniques and personalised medicine for cystic fibrosis. International Congress 2015 – Respiratory research in the Netherlands

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Personalised medicine for cystic fibrosis: treating the basic defect
Source: Eur Respir Rev 2013; 22: 3-5
Year: 2013


Intestinal organoids as ex vivo models for personalised medicine in cystic fibrosis
Source: International Congress 2018 – Organoids and pluripotent stem cells
Year: 2018


The impact of personalised therapies on respiratory medicine
Source: Eur Respir Rev 2013; 22: 72-74
Year: 2013



Progress in precision medicine in cystic fibrosis: a focus on CFTR modulator therapy
Source: Breathe, 17 (4) 210112; 10.1183/20734735.0112-2021
Year: 2021



Targeting miRNA-based medicines to cystic fibrosis airway epithelial cells using nanotechnology
Source: Annual Congress 2012 - Molecular biology of pro- and anti-inflammatory responses in the lung
Year: 2012

Is cystic fibrosis the hemi-neglected part of respiratory medicine?
Source: Virtual Congress 2021 – CCC Thoracic oncology
Year: 2021


Genomically-guided therapies: a new era for cystic fibrosis
Source: Virtual Congress 2020 – European Reference Network for rare lung diseases (ERN-LUNG): acting for improved cross-border management of rare diseases
Year: 2020


Practical microbiology of cystic fibrosis lung disease
Source: School Course 2013 - Cystic Fibrosis
Year: 2013

Personalised medicine in interstitial lung diseases
Source: Eur Respir Rev, 27 (148) 170117; 10.1183/16000617.0117-2017
Year: 2018



A new paradigm for the management of children with cystic fibrosis at home: experiences from a Dutch cystic fibrosis clinic
Source: Virtual Congress 2021 – New technologies for the management of children with respiratory diseases
Year: 2021


Effect of different physiotherapy devices on ventilation distribution in adults with cystic fibrosis
Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Year: 2013

Time to breathe: Progress in precision medicine in cystic fibrosis
Source: Short video discussion 2022
Year: 2022

Systems medicine advances in interstitial lung disease
Source: Eur Respir Rev, 26 (145) 170021; 10.1183/16000617.0021-2017
Year: 2017



Health-economic aspects of cystic fibrosis screening and therapy
Source: Eur Respir Monogr 2014; 64: 304-319
Year: 2014


Update on new treatments for cystic fibrosis
Source: Virtual Congress 2020 – Updates in cystic fibrosis
Year: 2020


Towards personalized medicine in idiopathic pulmonary fibrosis by screening exhaled volatiles in patients’ primary bronchial epithelial cells
Source: Virtual Congress 2020 – Cellular stress in respiratory diseases
Year: 2020


Implementation of non-medical prescribing within the clinical cystic fibrosis setting
Source: International Congress 2014 – Physiotherapy and physical activity in respiratory conditions
Year: 2014